Inhibition of DNA Topoisomerase I by Dihydrotanshinone I, Components of a Medicinal Herb Salvia miltiorrhiza Bunge

Bioscience, Biotechnology and Biochemistry

Volumn 63, Issue 8, 1999, Pages 1370-1373

  Lee, Dong Sun ^a,d   Lee, Sang Han ^a   Kwon, Gi Seok ^b   Lee, Hong Kum ^c   Woo, Joo Hyung ^a   Kim, Jong Guk ^a   Hong, Soon Duck ^a  

^a Kyungpook National University   (South Korea)

^b Andong National University   (South Korea)

^c Korea Research Institute of Ships and Ocean Engineering   (South Korea)

^d INST OF PHYS AND CHEMICAL RESEARCH   (Japan)

Author keywords

Dihydrotanshinone I; DNA intercalator; DNA topoisomerase I inhibitor

Indexed keywords

EID: 0013634223     PISSN: 09168451     EISSN: 13476947     Source Type: Journal    
DOI: 10.1271/bbb.63.1370     Document Type: Article

References (17)

1. Sutcliffe, J. A., Gootz, T. D., and Barrett, J. F., Biochemical characteristics physiological significance of major DNA topoisomerases. Antimicrob. Agents Chemother., 33, 2027-2033 (1989).
2. Liu, L. F., DNA topoisomerase poisons as antitumor drug. Annu. Rev. Biochem., 58, 351-375 (1989).
3. Covey, J. M., Jaxel, C., Kohn, K. W., and Pommier, Y., Protein-linked DNA strand breaks induced in mammalian cells by camptothecin, an inhibitor of topoisomerase. Cancer Res., 49, 5016-5022 (1989).
4. D’Arpa, P. and Liu, L. F., Topoisomerase-targeting antitumor drugs. Biochem. Biophys. Acta., 989, 163-177 (1989).
5. Hsiang, H. S., Hertzberg, R. P., and Liu, L. F., Campothecin induces protein-linked DNA breaks via mammalian DNA topoisomerase I. J. Biol. Chem., 260, 14873-14878 (1985).
6. Hsiang, Y. H., Liu, L. F., Wall, M. E., Wani, M. C., Nicholas, A. W., Manikumar, G., Kirschenbaum, S., Silber, R., and Potmesil, M., DNA topoisomerase I-mediated DNA cleavage and cytotoxicity of camptothecin analogues. Cancer Res., 49, 4385-4389 (1989).
7. Kawato, Y., Aonuma, M., Horota, Y., Kuga, H., and Sato, K., Intracellular roles of SN-38, a metabolite of the camptothecin derivative CPT-11 in the antitumor effect CPT-11. Cancer Res., 51, 4187-4191 (1991).
8. Pommier, Y., Minford, J. K., Schwartz, R. E., Zwelling, L. A., and Kohn, K. W., Effects of the DNA intercalators 4'-(9-acridinylamino)methanesulfon-m-anisidide and 2-methyl-9-hydroxyellipticinium on topoisomerase II mediated DNA strand cleavage and strand passage. Biochemistry, 24, 6410-6416 (1985).
9. Schneider, E., Hsiang, Y. H., and Liu, L. F., DNA topoisomerase as anticancer drug targets. Adv. Pharmacol., 21, 149-183 (1990).
10. Wang, J. C., DNA topoisomerases. Annu. Rev. Biochem., 54, 665-695 (1985).
11. Wang, J. C., Recent studies of DNA topoisomerases. Biochem. Biophys. Acta., 909, 1-9 (1987).
12. Yasumasa, L, Izumi, M., and Yutaka, T., Abietane type diterpenoids from Salvia miltiorrhiza. Phytochem., 28, 3139-3141 (1989).
13. Zhi, H. B. and Alfermann, A. W., Diterpenoid production in hairy root cultures of Salvia miltiorrhiza. Phytochem., 32, 699-702 (1993).
14. Yamashita, Y., Fujii, N., Murakata, C., Ashizawa, T., Okabe, M., and Nakano, H., Induction of mammalian DNA topoisomerase I-mediated DNA cleavage by antitumor indolocar-bazole derivatives. Biochemistry, 31, 12069-12075 (1992).
15. Yamashita, Y., Kawada, S. Z., Fujii, N., and Nakano, H., Induction of mammalian DNA topoisomerase I and II mediated DNA cleavage by saintopin, a new antitumor agent from fungus. Biochemistry, 30, 5838-5845 (1991).
16. Andoh, T., Ishii, K., Suzuki, Y., Ikegami, Y., Kusunoki, Y., Takemoto, Y., and Okada, K., Characterization of a mammalian mutant with a camptothecin-resistant DNA topoisomerase I. Proc. Natl. Acad. Sci. USA, 84, 5565-5569 (1987).
17. 4 DNA ligase by anthracyclines. Nucleic Acids Res., 16, 3907-3918 (1988).